March 1, 2021 Enzychem Lifesciences to Present at the 2021 NASH-TAG Conference Highlighting TLR Signaling Inhibition with Mosedipimod (EC-18) Explore further
February 8, 2021 Enzychem Lifesciences Announces Poster Presentation At AACR VirtualAnnual Meeting 2021 Explore further
January 26, 2021 Enzychem Lifesciences Receives NASA Grant Funding to Evaluate EC-18 as a Protective Agent for Radiation and Pathogen-Induced Tissue Damage and Inflammation in Space Explore further
October 2, 2020 ENZYCHEM LIFESCIENCES SELECTED TO PRESENT AT 2020 RADIATION RESEARCH SOCIETY ANNUAL MEETING Explore further
September 22, 2020 EC-18 COULD BE SOUTH KOREA’S NEXT GLOBAL BLOCKBUSTER DRUG BY KI YOUNG SOHN, CHAIRMAN OF ENZYCHEM LIFESCIENCES Explore further
